ph: 09 535 7218

Zoledronate (Aclasta) Infusion Subsidy

Maximum funding cap reached for 2018-19 funding year

Counties Manukau Health provides funding to subsidise zoledronate (aclasta) infusions for eligible patients.

Funding of a maximum of 300 patients is available per year.  For the period ending June 2019 this maximum funding allocation has now been reached.

Funding will resume 1st July 2019.  Please re-visit this page to apply for funding after this date.

All existing pre-appoved subsidy vouchers will be honoured.



This product has been added to your cart